14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60975 | Antitumor agent-50 | ||
Antitumor agent-50 (compound 1a) 是一种噻唑烷酮。Antitumor agent-50 作为一种有效的抗肿瘤剂,在骨肉瘤 (OS)的研究中具有潜力。 | |||
T72523 | Antitumor agent-46 | ||
Antitumor agent-46 是一种抗肿瘤剂。Antitumor agent-46 对 MCF-7 细胞具有明显更高的抗增殖活性,IC50值为 2.08 µM。 | |||
T72524 |
Antitumor agent-47
|
||
Antitumor agent-47 是一种具有抗肿瘤活性的水飞蓟宾衍生物。Antitumor agent-47 对 NCI-H1299 和 HT29 细胞具有细胞毒活性,IC50值分别为 8.07 µM 和 6.27 µM。 | |||
T60505 | Antitumor agent-43 | ||
Antitumor agent-43 (Compound 4B) 是一种有效的抗肿瘤剂,可诱导细胞周期阻滞在G2/M 期。Antitumor agent-43对 T-24 细胞的IC50值为0.5 μM。 | |||
T83009 |
Antitumor agent-107
|
||
Antitumor agent-107(化合物5h)是一款抗癌剂,对白血病细胞系展现出显著的抑制作用(GI50=0.32-1.34 μM)。该化合物对其他多种人类癌细胞系亦显示出了抗肿瘤活性(GI50值介于0.35-9.43 μM之间)。 | |||
T83007 |
Antitumor agent-120
|
||
Antitumor agent-120 (compound 1) 为一类黄酮化合物,来源于葛根提取。本化合物对LNCaP和PC3癌细胞的抑制作用不明显,表现出IC50s均大于50 μM。 | |||
T72525 |
Antitumor agent-48
|
||
Antitumor agent-48 是一种具有抗肿瘤活性的 2,3-dehydrosilybin 衍生物。Antitumor agent-48 对 MCF-7、NCI-H1299、HepG2 和 HT29 细胞具有细胞毒活性,IC50值分别为 8.06 µM、13.1 µM、16.51 µM 和 12.44 µM。 | |||
T60421 |
Antitumor agent-68
|
||
Antitumor agent-68 是一种有效的微管蛋白抑制剂,具有良好的抗肿瘤活性,对宫颈癌细胞系 HeLa 和乳腺癌细胞系 MCF-7 细胞的IC50值分别为 3.6 和 3.8 μM。Antitumor agent-68 以剂量依赖的方式表现出良好的 ROS 和DPPH 自由基的清除活性。 | |||
T61313 |
Antitumor agent-70
|
||
Antitumor agent-70 (compound 8b) is a highly potent multi-targeted kinase inhibitor, particularly targeting c-Kit. It demonstrates remarkable anti-tumor activity and the ability to induce cell apoptosis. This compound also exhibits strong inhibition of multiple myeloma, with an IC 50 value of 0.12 μM. Therefore, Antitumor agent-70 holds great potential as an effective therapy for combating cancer, especially in cases involving c-Kit. [1] | |||
T61996 |
Antiproliferative agent-6
|
||
Antiproliferative agent-6 (compound 8a) 是有效的抗肿瘤化合物。Antiproliferative agent-6 具有抗增殖活性,抑制癌细胞系 HCT116、MCF-7、H460 和非肿瘤非整倍体永生角质细胞 HaCaT 的 GI50分别为 0.5 μM、2 μM、0.7 μM 和 3.5 μM。 | |||
T75078 | Antitumor agent-86 | Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
Antitumor agent-86 (compound 5a) 对MCF-7乳腺癌细胞线具有IC50值2.62 µM的抑制活性。该化合物通过促进细胞凋亡和引发细胞周期阻滞来表现其抗癌效能,并对RAS/PI3K/Akt/JNK信号传导途径具有靶向作用。 | |||
T9684 |
(Z)-Orantinib
|
||
(Z)-Orantinib ((Z)-SU6668) 是一种有效,选择性,具有口服活性和 ATP 竞争性的 Flk‐1/KDR,PDGFRβ和 FGFR1抑制剂,IC50值分别为 2.1,0.008 和 1.2 μM。(Z)-Orantinib 是有效的抗血管生成和抗肿瘤剂,可诱导已形成的肿瘤消退。 | |||
T60704 |
Loxoprofen sodium (dihydrate)
|
||
Loxoprofen sodium dihydrate 是一种非甾体类口服抗炎药,具有镇痛和解热作用。Loxoprofen sodium dihydrate 显示出抗肿瘤活性,并且可减少动脉粥样硬化。Loxoprofen sodium dihydrate 是COX 的非选择性抑制剂,对 COX-1 和 COX-2 的IC50值分别为 6.5 和 13.5 μM。 | |||
T71261 | Arsthinol | ||
Arsthinol is an antiprotozoal agent which may have anti-cancer activity. It was found that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD50/IC50. Arsthinol induced growth inhibition of NB4 cells at lower concentration (IC50 (concentration inhibiting growth by 50%) = 0.78 +/- 0.08 micromol/l after 24 h) than As(2)O(3) (IC50 = 1.60 +/- 0.23 micro... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75563 | Vanicoside E | ||
Vanicoside E 是一种抗氧化和抗癌剂。Vanicoside E 抑制L-Tyrosine 和L-DOPA,IC50为 45.23 μM 和 189.96 μM。 |